Kopin L, Lowenstein CJ, Dyslipidemia. Ann Intern Med. 2017;167(11):ITC81–96.
Jones L, Downie LE, Korb D, Benitez-Del-Castillo JM, Dana R, Deng SX, et al. TFOS DEWS II Management and Therapy Report. Ocul Surf. 2017;15(3):575–628.
Bafei SEC, Zhao X, Chen C, Sun J, Zhuang Q, Lu X, et al. Interactive effect of increased high sensitive C-reactive protein and dyslipidemia on cardiovascular diseases: a 12-year prospective cohort study. Lipids Health Dis. 2023;22(1):95.
Article CAS PubMed PubMed Central Google Scholar
Dongway AC, Faggad AS, Zaki HY, Abdalla BE. C-reactive protein is associated with low-density lipoprotein cholesterol and obesity in type 2 diabetic Sudanese. Diabetes Metabolic Syndrome Obesity: Targets Therapy. 2015;8:427–35.
Wu L, Parhofer KG. Diabetic dyslipidemia. Metab Clin Exp. 2014;63(12):1469–79.
Article CAS PubMed Google Scholar
Mavromati M, Jornayvaz FR. Hypothyroidism-Associated Dyslipidemia: potential molecular mechanisms leading to NAFLD. Int J Mol Sci. 2021;22(23).
Yang W, Yang K, Pan Y, Wu S, Chen X, Shen L, et al. A literature-derived dataset on risk factors for dry eye disease. Sci Data. 2023;10(1):21.
Article PubMed PubMed Central Google Scholar
Hong N, Lin Y, Ye Z, Yang C, Huang Y, Duan Q, et al. The relationship between dyslipidemia and inflammation among adults in east coast China: a cross-sectional study. Front Immunol. 2022;13:937201.
Article CAS PubMed PubMed Central Google Scholar
AlMuhaidib S, AlBuhairan F, Tamimi W, AlDubayee M, AlAqeel A, Babiker A, et al. Prevalence and factors associated with dyslipidemia among adolescents in Saudi Arabia. Sci Rep. 2022;12(1):16888.
Article CAS PubMed PubMed Central Google Scholar
Pan L, Yang Z, Wu Y, Yin R-X, Liao Y, Wang J, et al. The prevalence, awareness, treatment and control of dyslipidemia among adults in China. Atherosclerosis. 2016;248:2–9.
Article CAS PubMed Google Scholar
Kolovou GD, Anagnostopoulou KK, Damaskos DS, Bilianou HI, Mihas C, Milionis HJ, et al. Gender differences in the lipid profile of dyslipidemic subjects. Eur J Intern Med. 2009;20(2):145–51.
Article CAS PubMed Google Scholar
Correa R, Wayar F, Reaven P, Corpas E. Dyslipidemia in the Elderly. Endocrinology of Aging: Elsevier; 2021. pp. 607–50.
Vekic J, Stefanovic A, Zeljkovic A. Obesity and dyslipidemia: a review of current evidence. Curr Obes Rep. 2023:1–16.
Alamri S, Almalki MD, Alotaibi WN, Althobaiti S. The prevalence of dyslipidemia in obese patients. Int J Med Developing Ctries. 2019;3(1):006–9.
Kim K-i. Dyslipidemia in older adults and management of dyslipidemia in older patients. J Lipid Atherosclerosis. 2015;4(1):1–6.
McCulley JP, Shine W. A compositional based model for the tear film lipid layer.A compositional based model for the tear film lipid layer. Trans Am Ophthalmol Soc. 1997;95:79–93.
CAS PubMed PubMed Central Google Scholar
Osae EA, Steven P, Redfern R, Hanlon S, Smith CW, Rumbaut RE et al. Dyslipidemia and Meibomian Gland Dysfunction: utility of Lipidomics and experimental prospects with a Diet-Induced obesity mouse model. Int J Mol Sci. 2019;20(14).
Chun YH, Kim HR, Han K, Park YG, Song HJ, Na KS. Total cholesterol and lipoprotein composition are associated with dry eye disease in Korean women. Lipids Health Dis. 2013;12:84.
Article CAS PubMed PubMed Central Google Scholar
Tavares Fde P, Fernandes RS, Bernardes TF, Bonfioli AA, Soares EJ. Dry eye disease. Semin Ophthalmol. 2010;25(3):84–93.
Dao AH, Spindle JD, Harp BA, Jacob A, Chuang AZ, Yee RW. Association of dyslipidemia in moderate to severe meibomian gland dysfunction. Am J Ophthalmol. 2010;150(3):371–5.
Wang T-H, Tsai Y-J, Wang Y-H, Wu C-L, Lin I-C. Relationship between Dry Eye Disease and Dyslipidemia: a systematic review. J Clin Med. 2023;12(20):6631.
Article CAS PubMed PubMed Central Google Scholar
Wang TJ, Wang IJ, Hu CC, Lin HC. Comorbidities of dry eye disease: a nationwide population-based study. Acta Ophthalmol. 2012;90(7):663–8.
Blaton V. How is the metabolic syndrome related to the Dyslipidemia? Ejifcc. 2007;18(1):15–22.
PubMed PubMed Central Google Scholar
Swastini DA, Wiryanthini IAD, Ariastuti NLP, Muliantara A. Atherosclerosis prediction with high sensitivity C-reactive protein (hs-CRP) and related risk factor in patient with dyslipidemia. Open Access Macedonian J Med Sci. 2019;7(22):3887.
Alhalwani AY, Baqar R, Algadaani R, Bamallem H, Alamoudi R, Jambi S et al. Investigating neutrophil-to-lymphocyte and C-Reactive protein-to-albumin ratios in type 2 Diabetic patients with Dry Eye Disease. Ocul Immunol Inflamm. 2023:1–7.
Pepys MB, Hirschfield GM. C-reactive protein: a critical update. J Clin Investig. 2003;111(12):1805–12.
Article CAS PubMed PubMed Central Google Scholar
Sheinenzon A, Shehadeh M, Michelis R, Shaoul E, Ronen O. Serum albumin levels and inflammation. Int J Biol Macromol. 2021;184:857–62.
Article CAS PubMed Google Scholar
Szabó MZ, Szodoray P, Kiss E. Dyslipidemia in systemic lupus erythematosus. Immunol Res. 2017;65:543–50.
Popadic V, Brajkovic M, Klasnja S, Milic N, Rajovic N, Lisulov DP, et al. Correlation of dyslipidemia and inflammation with obstructive sleep apnea severity. Front Pharmacol. 2022;13:897279.
Article CAS PubMed PubMed Central Google Scholar
Dessein PH, Joffe BI, Stanwix A, Botha AS, Moomal Z. The acute phase response does not fully predict the presence of insulin resistance and dyslipidemia in inflammatory arthritis. J Rhuematol. 2002;29(3):462–6.
Zhang Y, Li S, Xu R-X, Zhu C-G, Guo Y-L, Wu N-Q et al. Systemic inflammatory markers are closely associated with atherogenic lipoprotein subfractions in patients undergoing coronary angiography. Mediators of Inflammation. 2015;2015.
Zhang Y, Li S, Xu R-X, Zhu C-G, Guo Y-L, Wu N-Q, et al. Systemic inflammatory markers are closely Associated with atherogenic lipoprotein subfractions in patients undergoing coronary angiography. Mediat Inflamm. 2015;2015:235742.
Del Rincón I, Williams K, Stern MP, Freeman GL, O’Leary DH, Escalante A. Association between carotid atherosclerosis and markers of inflammation in rheumatoid arthritis patients and healthy subjects. Arthritis Rheumatism: Official J Am Coll Rheumatol. 2003;48(7):1833–40.
Sonmez O, Sonmez M. Role of platelets in immune system and inflammation. Porto Biomedical J. 2017;2(6):311–4.
PaŞAoĞLu Ö, PaŞAoĞLu H. Elevated monocyte to HDL ratio as a new inflammatory marker in patients with dry eye. New Front Ophthalmol. 2018;4(6).
Durmus E, Kivrak T, Gerin F, Sunbul M, Sari I, Erdogan O. Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio are predictors of Heart failure. Arq Bras Cardiol. 2015;105(6):606–13.
PubMed PubMed Central Google Scholar
Chen JH, Zhai ET, Yuan YJ, Wu KM, Xu JB, Peng JJ, et al. Systemic immune-inflammation index for predicting prognosis of colorectal cancer. World J Gastroenterol. 2017;23(34):6261–72.
Article PubMed PubMed Central Google Scholar
Meng Y-F, Pu Q, Ma Q, Zhu W, Li X-Y. Neutrophil/lymphocyte ratio as an inflammatory predictor of dry eye disease: a case-control study. Ther Clin Risk Manag. 2021:259–66.
Ozarslan Ozcan D, Kurtul BE, Ozcan SC, Elbeyli A. Increased systemic immune-inflammation index levels in patients with dry eye disease. Ocul Immunol Inflamm. 2022;30(3):588–92.
Amalia M, Saputri F, Sauriasari R, Widyantoro B. Complete blood count, lipid profiles, and inflammatory markers associated with atherosclerotic cardiovascular disease in patients with diabetes [version 1; peer review: awaiting peer review]. F1000Research. 2023;12(1470).
Ji H, Li Y, Fan Z, Zuo B, Jian X, Li L, et al. Monocyte/lymphocyte ratio predicts the severity of coronary artery disease: a syntax score assessment. BMC Cardiovasc Disord. 2017;17:1–8.
留言 (0)